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Abstract
Background: Apoptosis, or programmed cell death is a form of physiological cell death. It is
increased or decreased in the presence of infection, inflammation or tissue remodelling. Previous
studies suggest that apoptosis is involved in the pathogenesis of inflammatory periodontal disease.
The aim of the present study was to investigate the clinical features and known indicators of
apoptosis (p53, Bcl-2, Caspase-3) in patients with generalized aggressive periodontitis (GAP)
Methods: Eight patients with GAP, who had sites with probing depths (PD) > 5 mm, and 10
periodontally-healthy persons were included in the study. Clinical examinations and PD were
performed, and the plaque index and gingival index were recorded. Gingival tissues biopsies were
obtained from active site of each patient and from healthy individuals. The expression of caspase-
3, Bcl-2, and p53 was evaluated by immunohistochemistry
Results: There were no significant differences between GAP and control group with respect to
levels of caspase-3 and p53 expression (P > 0.05). Contrary, the frequency of grade 3 expression
of Bcl-2 was higher in GAP group than the control group.
Conclusion: The higher frequency of Bcl-2 expression in GAP group indicates and delayed
apoptosis can lead to increasing resident inflammatory cells in periodontal tissues and resulting in
progressive periodontal destruction.
Background
Inflammatory periodontal diseases are characterized as
local and peripheral infection involving multiple species
of gram-negative organisms. Actinobacillus actinomycetem-
comitans (aa) is an anaerobic gram-negative rod which is
considered to be one of the major etiological agents of
chronic periodontitis [1]. The local host response to aa
includes the recruitment of neutrophils and the subse-
quent release of inflammatory mediators and cytokines,
which appear to play an important role in the pathogene-
sis of periodontal disease. The mechanisms responsible
for gingival tissue damage are poorly understood, and
both immune-mediated reactions and direct cytopathic
effects of bacteria may be involved. Based on a direct effect
of bacteria in cell cultures, it has been suggested that
apoptosis might play an important role in periodontitis.
However, the nature of molecular mechanisms participat-
ing in this process remain unknown
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logic process that contributes to maintaining tissue home-
ostasis [3]. The process of apoptosis can be modulated by
various stimuli, including hormones, cytokines, growth
factors, bacterial or viral infections, and immune
responses [4]. Recent studies demonstrate that apoptosis
is essentially mediated by a family of cysteine proteases,
called caspases, which can be grouped into initiator and
effector caspases. Initiator caspases, such as caspase-8 or -
9, exert regulatory roles by activating downstream effector
caspases, such as caspase-3, -6, or -7, which cleave various
cellular substrates [5]. Caspase-3 is considered an executor
enzyme since it can be activated by several other active
caspases, and because it has catalytic specificity for a rele-
vant number of critical cellular substrates. One reliable
indication of the induction of is detection of cells that
express the active form of caspase-3 [6]. In fact, presence
of cells that are positive for active caspase-3 is considered
a hallmark of apoptosis activation.
Among other factors, the products of two genes that
encode proteins p53 and Bcl-2 have been shown to play a
fundamental regulatory role in apoptosis [7,8]. Bcl-2 is a
member of a family of anti-apoptotic proteins that can
prevent or reduce cell death induced by a variety of stimuli
[9]. The intrinsic death pathway is initiated by the mito-
chondrial release of cytochrome c, a process that is inhib-
ited by anti-apoptotic Bcl-2 proteins. Conversely p53 is
the protein product of a tumor-suppressor gene, and
expression of p53 can induce apoptosis. This protein is
also implicated in the regulation of tissue dynamics, and
is specifically thought to induce apoptosis in terminally
differentiated cells, including inflammatory cells [10].
Various periodontal pathogens including Porphyromonas
gingivalis, Actinobacillus actinomycetemcomitans, and
Eikenelle Corrodens have been reported to induce cytotox-
icty in a variety of cellular components of the periodon-
tium. Based on a direct cytopathic effect of bacteria in cell
cultures, it has been suggested that apoptosis might play
an important role in periodontitis [11-13]. Moreover,
lipopolysaccharides (LPS), a common component of the
cell wall of gram-negative bacteria stimulate butyric acid-
induced apoptosis in human peripheral blood mononu-
clear cells, and a toxin from aa induces apoptosis in B lym-
phocytes present in the periodontal tissue [11,14,15]. The
induction of apoptosis in the host's cells provoked by cer-
tain pathogens, or their products, is a phenomenon
involved in the pathogenesis of periodontal diseases. Bac-
terial phagocytosis or exposure to different bacterial com-
ponents such as LPS, may delay apoptosis of the PMNs
[16]. Berker et al demonstrated that neutrophil apoptosis
provided a signal to monocytes, changing the phenotype
of the monocyte resulting in the production of anti-
inflammatory cytokines and suppression of proinflamma-
tory cytokines in response to LPS [17].
All these data indicate that apoptotic mechanisms seem to
play an important role in the pathogenesis of periodontal
diseases. Despite the elucidation of apoptotic signaling
cascades, it is almost completely unknown whether and to
which extent caspases are activated in human gingival
pathologies. The aim of this study was to compare quan-
tities of immunohistochemically identified p53, Bcl-2 and




The criterion for inclusion of GAP patients (3 males and 5
females; age range, 26–39 years; mean age, 34.12 ± 4.54
years) was generalized loss of proximal attachment, affect-
ing at least 3 teeth other than the incisors and first molars.
At least 5 or 6 teeth in each GAP patient had sites with PD
≥ 5 mm (mean PD: 4.4 ± 0.7 mm), and all selected
patients showed extensive associated bone loss on radio-
graphs At the time of examination, none of the GAP
patients had been treated. The 10 control subjects (4
males and 6 females; age range, 14–32 years; mean age,
24.70 ± 7.13 years) had no history of periodontal disease.
None of the subjects had any known systemic disorder or
had used antibiotics and anti-inflammatory medications
in the last 3 months. Patient and control subjects with
active infectious diseases such as hepatitis, HIV infection,
and tuberculosis or chronically treated with medications
(phenytoin, cyclosporin-A, or calcium channel blockers),
as well as females, who were lactating or pregnant, were
excluded. Probing depths in control group were <3 mm,
and none of the controls showed loss of attachment, clin-
ical evidence of inflammation, or bone loss on radio-
graphs.
Clinical examination and measurements
In each of the 18 total subjects, the quantity of microbial
dental plaque present was determined using the Silness
and Löe plaque index (PI) [18], and gingival status was
assessed using the Löe and Silness gingival index (GI)
[19]. Periodontal probing depths (PD) were measured to
the nearest millimeter using periodontal probe. PI and GI
were evaluated at 6 sites per tooth (mesio-vestibular, mid-
vestibular, disto-vestibular, mesio-palatinal, mid-palati-
nal, and disto-palatinal). Clinical parameters were
recorded for the entire dentition.
Sampling of gingival tissue
Gingival tissue biopsies were obtained under local
anesthesia from 8 patients diagnosed with GAP. The site
with probing depth >5 mm were chosen for biopsy inPage 2 of 7
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to 2 mm subgingivally. The specimens consisted of gingi-
val epithelium and gingival connective tissue. The control
specimens were obtained from 10 healthy controls with
no periodontal disease during extraction of third molars
Informed consent was obtained before the biopsy proce-
dure, and one sample was collected from each subject.
Tissue processing and immunohistochemistry
All biopsies were fixed in formalin and embedded in par-
affin blocks. Several 4 mm-thick sections were obtained
from each block and prepared with hematoxylin and
eosin (H&E). Briefly, for immunohistochemical study, 3
mm-thick sections were deparaffinized and mounted on
slides coated with poly-L-lysine. The sections were placed
in citrate buffer (0.01 mol/L, pH 6), heated in a micro-
wave oven for 15 minutes at maximum power (700 W),
and then cooled at room temperature for 20 minutes. The
sections were then incubated with primary antibodies for
p53 (Ready-to-use Ab-5, NeoMarkers, Fremont, CA, USA),
Bcl-2 (Ready-to-use Ab-1, NeoMarkers, Fremont, CA,
USA), and caspase-3 (Ready-to-use Ab-5, NeoMarkers,
Fremont, CA, USA) for 2 hours in a humidified chamber
at room temperature. After washing in buffer, each slide
was incubated with biotinylated goat anti-polyvalent for
15 minutes at room temperature, and thereafter in strepta-
vidine peroxidase for another 15 minutes at room temper-
ature. Slides were then developed for 12 minutes in
diaminobenzidine (DAP, NeoMarkers, Fremont, CA,
USA), followed by counterstaining with hematoxylin.
Colon adenocarcinoma (for p53) and tonsil tissue (for
Bcl-2) were used as positive controls for immunostaining.
Levels of expression of p53 and Bcl-2 on each slide were
graded in a semiquantitative fashion using a scale of 0 to
3+: (0) = no staining; (1+) = stained cells comprising
>10% of the inflammatory infiltrate (2+) = stained cells
comprising 30% of the inflammatory infiltrate, and (3+)
= stained cells comprising >30% of the inflammatory
infiltrate. Expression of caspase-3 was graded in a semi-
quantitative manner using a two-tier scale: (0) = staining
cells <30% of the inflammatory infiltrate or (1+) = stain-
ing >30% of the inflammatory infiltrate.
Statistical analysis
Data for the clinical parameters were expressed as mean ±
standard deviation. Differences in clinical parameters and
histological findings between the GAP and control groups
were analyzed using the Student's t-test. A statistical soft-
ware package (SPSS), Version 10.0 for Windows, SPSS Inc.,
Chicago, IL.) was used and changes were considered signif-
icant at the p < 0.05 levels.
Results
The data for age and periodontal status in both groups are
presented in Table 1. Eight patients (mean age 34.12 ±
4.54) with GAP and ten healthy individuals (mean age
24.7 ± 7.13) were selected for this study. There were sig-
nificant differences between the groups with respect to age
and PD, but not GI or PI (P < 0.05).
Immunohistochemical findings are shown in Table 2.
There were no differences between the groups with respect
to grades of caspase-3 and p53 expression (Figures 1 and
2, respectively) (P > 0.05). However, the frequency of
grade 3+ expression of Bcl-2 was significantly higher in the
GAP group than that of the control group (Figure 3) (P <
0.05).
Discussion
While GAP affects a minority of periodontal patients, it is
highly significant due to severe tissue destruction.
Although the presence of bacterial pathogens is necessary
for the initiation of periodontal diseases, complex inflam-
matory and immune response also play a critical role in
the progression of disease [20,21].
Apoptosis, or programmed cell death, plays a critical role
in the regulation of inflammation and the host immune
response. During this process, a series of coordinated
morphological and biochemical events is induced in the
affected cell, resulting in its death and subsequent
removal by scavenger phagocytes [3]. Gamonal and cow-
orkers studied gingival tissues from patients with chronic
periodontitis and from healthy controls [22]. They exam-
ined sections of gingival tissues by electron microscopy
and performed immunohistochemical analysis to detect
DNA fragmentation-positive cells and active caspase 3,
Fas/FasL, Bcl-2 and p53-positive cells. Positive staining for
Table 1: Mean clinical findings in GAP patients and controls.
GAP Group (N = 8) Control Group (N = 10)
Age (yrs) 34.12 ± 4.54 * 24.7 ± 7.13
Probing depth (mm) 4.44 ± 0.75 * 2.22 ± 0.36
Gingival index 1.01 ± 0.21 1.10 ± 0.32
Plaque index 1.52 ± 0.54 1.10 ± 0.29
* Significant difference (P < 0.05)Page 3 of 7
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infiltrates was only observed in the inflammatory infil-
trate from the chronic periodontitis biopsies, whereas Bcl-
2-positive cells was present in the tissues from both
Significant nuclear staining for p53 was observed in the mononuclear inflammatory cells in the GAP group specimensFigure 1
Significant nuclear staining for p53 was observed in the mononuclear inflammatory cells in the GAP group specimens. (×200 
p53 immunostaining).
Table 2: The distribution of stained cells in GAP patients and the controls.
GAP Group Control Group
N % N %
Cas-3 grade 0 4 50 6 60
Cas-3 grade 1 4 50 4 40
p53 grade 1 - - 4 40
p53 grade 2 5 62.5 2 20
p53 grade 3 3 37.5 4 40
Bcl-2 grade 1 - - 6 60
Bcl-2 grade 2 2 25 4 40
Bcl-2 grade 3 6 75 * - -
* Significant difference (P < 0.05)Page 4 of 7
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apoptotic cells by electron microscopy in the deep area of
biopsies from sites with probing depth ≥ 5 mm and
attachment with ≥ 3 mm. These results showed that apop-
totic cells were detected in the gingival tissue adjacent to
>6 mm sulci. This study strongly supported the relevance
of the apoptotic mechanisms in the selection of immuno-
compotent cell population in periodontal tissues.
Our study compared clinical findings and expression of
p53, Bcl-2 and caspase-3 in patients with GAP versus
healthy controls. We found no significant differences
between these groups with respect to overall frequency of
caspase-3 expression or frequencies of different grades of
expression of p53. However, staining for Bcl-2 was more
frequent in the GAP specimens than in the controls.
Certain activators of apoptosis require the presence of a
functional p53 protein. P53 is a tumor suppressor protein
which, when active, induces genes related to cell cycle reg-
ulation, DNA repair mechanisms, and the induction of
apoptosis [23]. Although p53 is present in normal tissues
and cells, its short half-life make its expression almost
undetectable in healthy normal tissues [24]. Upon activa-
tion, p53 stabilized so that its expression can be detected
with anti-p53 antibodies using standard immunohisto-
chemical techniques. This explain our finding that the
staining cell of p53 was similar between in both groups.
Thus, our data suggests that the exact mechanism of p53-
dependent apoptosis remains to be identified.
Apoptosis may therefore be an important phenomenon in
the regulation of the inflammatory response against
chronic bacterial accumulation, affecting both the
increase in cellularity and extent of the inflammatory
infiltration [25]. The process of apoptosis involves activa-
tion of a series of cysteine-type proteases that are named
caspases because of their catabolic properties [10]. These
enzymes are synthesized as inactive proenzymes, which
are then processed in cells that undergo apoptosis. Cas-
The diffuse mononuclear inflammatory cell infiltrate beneath the epithelium in a GAP specimen shows significant Bcl-2 stainingFigure 2
The diffuse mononuclear inflammatory cell infiltrate beneath the epithelium in a GAP specimen shows significant Bcl-2 staining. 
(×100 Bcl-2 immunostaining).Page 5 of 7
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Detection of active caspase-3-positive inflammatory cells
is evidence that apoptotic mechanisms are probably
underway. However, the small numbers of positive cells
for these apoptosis markers suffer a significant loss of
affinity to tissue, suggesting that the tissue destruction tak-
ing place in this condition may occur after a long time of
evolution. Although we aimed to evaluate the reduction
of apoptosis in the GAP group, we could not demonstrate
any significant difference between the positive staining
cells of caspase-3 in both groups. An increase in sample
size may result in statistical significance in further studies.
Mamalian Bcl-2 protein family of apoptosis-associated
proteins consists of members that inhibit apoptosis (Bcl-
2, Bcl-xl) and others that induced apoptosis (Bax, Bak,
etc.) [26]. Aberrant apoptosis regulation is considered to
contribute to autoimmune disorders such as systemic ery-
thematosus such as rheumatoid arthritis, viral diseases
including AIDS and bacterial infection [27-29]. Therefore,
abnormalities in the regulation of cell homeostasis may
contribute to a number of different pathogenic processes.
As noted, these anti-apoptotic proteins can prevent or
limit cell death induced by different stimuli [30,31].
Recent studies show that the bacterial products isolated
from different strains Porphyromonas gingivalis delay
neutrophil apoptosis in a dose-dependent fashion [32].
Certain cytokines increase the lifespan of the neutrophils
by inhibiting their apoptotic cell death in vitro and this
prolonged neutrophil survival has been associated with
an enhanced inflammatory response [33,34]. Gamanol et
al showed a positive correlation between the delay in the
apoptotic process of neutrophils in periodontal tissues
with an increase in the levels of tumor necrosis factor-
alpha (TNF-α), granulocyte monocyte-colony stimulating
factor (GM-CSF) and low expression of Bax, thus suggest-
Diffuse significant caspase-3 staining was observed in the inflammatory cells in the GAP specimensFig r  3
Diffuse significant caspase-3 staining was observed in the inflammatory cells in the GAP specimens. (×200 Caspase-3 immunos-
taining).Page 6 of 7
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pathogenesis of periodontitis [35]. The higher frequency
of Bcl-2 positivity in our GAP group indicates that delayed
apoptosis can lead to inflammatory cells staying locally in
periodontal tissues longer and thus secreting excessive
cytokines, finally to progressive periodontal destruction.
Our data indicate that host-mediated mechanisms are
involved in periodontitis-associated tissue damage. More-
over, the finding that tissue injury is associated with ele-
vated Bcl-2 activation could open up new diagnostic
possibilities and therapeutic strategies to prevent tissue
destruction in periodontal disease.
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